Genomic Origin and EGFR-TKI Treatments of Pulmonary Adenosquamous Carcinoma
Beyond finding druggable targets and tumor mutational burden: to measure heterogeneity by ctDNA
Perioperative chemoimmunotherapy in a patient with stage IIIB non-small cell lung cancer
P1.03-39 Intra-Tumoral CD61+ Megakaryocytes Predicts Poor Prognosis in Non-Small Cell Lung Cancer
P2.17-36 Molecular Markers, Therapeutic and Prognostic Analysis of Lung Sarcomatoid Carcinomas
Esophageal cancer in elderly patients: a population-based study.
Focusing on early detection and diagnosis-a way to eradicate deadly lung cancer.
A new approach to predict lymph node metastasis in solid lung adenocarcinoma: a radiomics nomogram.
The role of liquid biopsy in predicting post-operative recurrence of non-small cell lung cancer.
Esophageal cancer in patients under 50: a SEER analysis.
Deep learning aided decision support for pulmonary nodules diagnosing: a review
533PPD-(L)1 inhibitors vs chemotherapy vs their combination in front-line treatment of NSCLC
456POptimal starting age for lung cancer screening with low-dose CT: A population level analysis
The Optimal Treatment for Stage IIIA-N2 Non-small-cell Lung Cancer: A Network Meta-analysis
Prediction of potential for organ donation after circulatory death in neurocritical patients.
Prognosis of primary tracheal tumor: A population-based analysis.
Nomogram prediction for the survival of the patients with small cell lung cancer.
Association of EGFR mutations with ERCC1 expression in non-small cell lung cancer.
Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.
Surgical treatment for primary pulmonary lymphoepithelioma-like carcinoma.
A bayesian network meta-analysis of different agents or regimens as second-line treatment for SCLC.
Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: A meta‐analysis